What are you searching for?

28.01.2020 | Tracker

EMA Approvals tracker: HCPs anticipating 2020 approvals

By Laura McIntyre

Even though quieter during the holidays, the online HCP conversation relating to EMA approvals still spiked following key EMA decisions.

HCPs quickly responded to Janssen’s Spravato (esketamine) receiving EMA approval for treatment-resistant major depressive disorder in adults. They shared a BMJ article reporting the news and a press release from Business Wire.

https://twitter.com/joannamoncrieff/status/1209086175086030848

Out of 37 product-related mentions over the time period, the Spravato approval was mentioned 21 times.

Other approvals discussed by HCPs included looking back at Merck’s Ebola vaccine Ervebo approval that happened back in October and BMS Revlimid (lenalidomide) combination with rituximab for the treatment of relapsed or refractory follicular lymphoma.

HCPs in UK foresee challenges while awaiting EMA approvals

HCPs also showed anticipation for some of the novel therapies being approved by EMA in the near future. UK HCPs stated that the UK needs Trikafta (elexacaftor, ivacaftor and tezacaftor), a new breakthrough therapy for cystic fibrosis, as soon as it is approved in Europe, and wondered how Brexit is going to affect the access to the medicine.

https://twitter.com/RacheyCole/status/1215938264630222850

Another anticipated EMA approval is Enhertu (trastuzumab deruxtecan), a metastatic breast cancer treatment by AstraZeneca. HCPs encouraged one another that the EMA approval will soon follow, but admitted there may be a challenge getting it on the NHS.

We are tracking the HCP reaction to EMA approvals and related topics each month. You can keep up to date with this and other pharmaceutical tracking updates, including FDA drug approvals, within the Tracking section of CREATION Knowledge or by signing up our monthly newsletter.


READ LAST MONTH’S EMA APPROVAL TRACKER:

https://creation.co/knowledge/new-ema-approval-in-rheumatoid-arthritis-catches-hcp-attention/

Methodology notes:

  • Data for this research was analysed from the online Twitter conversations of HCPs talking about EMA approvals in English language (all other languages are available), between December 15th 2019 and January 14th 2020.
  • Between December 15th 2019 and January 14th 2020, 59 HCPs posted relating to EMA approvals 76 times all over the world.

View all articles >

Meet the Author

Laura McIntyre

As a Health Strategy Consultant Laura combines her passion for people with skills in project management and communications as she supports our clients through every step during and following a project. Outside work Laura is passionate about music, previously traveling the world as a professional opera singer.

Suggested next


15.04.2019 | Article

Healthcare professionals excited by emerging treatments for prostate cancer

Healthcare professionals excited by emerging treatments for prostate cancer

By Nathan Cripps

05.10.2017 | Case Study

Launching a first-in-class therapy in Europe

Launching a first-in-class therapy in Europe

By CREATION.co

View all articles >